Blog

Precision Tactics in HER2-Positive GI Malignancies – Colorectal Cancer Alliance

Photo from Colorectal Cancer Alliance/X

May 29, 2024, 16:03

Precision Tactics in HER2-Positive GI Malignancies – Colorectal Cancer Alliance

Colorectal Cancer Alliance shared a post on X:

“Join Yelena Y. Janjigian, Shubham Pant and Dr. Strickler as they discuss treatment plans with HER2-targeted therapies for GI malignancies and where these options fit in current guideline recommendations. 5/31 at 6:30 PM CDT at ASCO24! With Peer View and Cholangiocarcinoma Foundation.”

ASCO24 cancer Cholangiocarcinoma Foundation Colorectal Cancer Alliance Dr. Strickler GI Malignancies HER2-targeted therapies OncoDaily Oncology Peer View Shubham Pant Yelena Y. Janjigian

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage